NCT07477366 2026-03-17Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin LymphomaImmunityBio, Inc.Phase 2 Not yet recruiting20 enrolled
NCT03169790 2025-02-24QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHLImmunityBio, Inc.Phase 1/2 Withdrawn
NCT02384954 2024-07-03QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With RituximabAltor BioSciencePhase 1/2 Terminated43 enrolled 15 charts